Literature DB >> 24051125

[T plasty for the treatment of skin forehead defects].

O Marco1, D Boccara2, M Mimoun2, J Luini2, M Chaouat2.   

Abstract

INTRODUCTION: The closure of the skin defect of the forehead area with local flap must prevent the distortions of the eyebrow and hairlines and must limit the visibility of the scars. The H plasty is the most common procedure to treat this kind of defect but the scars are extensive and numerous. The H cutaneous flap presents necrosis risks if the skin is thin and the defect important. The H musculocutaneous flap presents sensitive and motors lesions risks. The T cutaneous flap is a good choice because of its excellent cosmetic result and minimized risks.
MATERIALS AND METHODS: Twenty-six patients have been treated by the same surgeon between 2006 and 2012 with T cutaneous flap in order to treat forehead and temples' skin defects (the surface goes from 1.5 to 15cm).
RESULTS: Excisions were completed in the every 26 cases. We had excellent cosmetic result and no complications such as necrosis, infection, sensitive and motor troubles after the surgery. DISCUSSION: The T plasty is easy for treating skin forehead defects. The scars are 25% less extensive than with a H plasty. The T flap permits to treat important defects without distortion or risks.
CONCLUSION: The T cutaneous flap can easily substitute the H plasty for the forehead and temples reconstruction with no risks but good cosmetics results.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Carcinoma; Carcinome; Flap; Forehead; Front; Lambeau; Plastie en T; T plasty

Mesh:

Year:  2013        PMID: 24051125     DOI: 10.1016/j.anplas.2013.07.006

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  1 in total

1.  Skin oncoplasties: O-to-Z technique a technique of choice in situation of limited resources? Case of Burkina Faso.

Authors:  Nayi Zongo; N L Marie Ouedraogo; Mamadou Windsouri; Laure S C Yameogo; Thierry R Kouchika Chabi; Pascal Niamba; Adama Traore
Journal:  World J Surg Oncol       Date:  2022-04-07       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.